Arsanis, Inc., a biotechnology company dedicated to the development of anti-infective monoclonal antibodies, today announced the establishment of its Scientific Advisory Board to include six internationally recognized opinion leaders in the areas of infectious diseases and monoclonal antibody engineering.
